Patent · US Active

Inhibitors of hepatitis C virus

US10335409B2 · kind B2 · utility

1Cited by
28References
2Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 11, 2018
Grant dateJul 2, 2019
Priority date—
Expiry dateJun 11, 2038

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula I are disclosed As well as pharmaceutically acceptable salts thereof. Methods of using said compounds and pharmaceutical compositions containing said compounds are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.